Opiant Pharmaceuticals, Inc. Profile
Industry
BiotechnologySector
HealthcareNumber of Employees
37Opiant Pharmaceuticals's Business Model
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overdose; and opioid use disorders. The company was formerly known as Lightlake Therapeutics Inc. and changed its name to Opiant Pharmaceuticals, Inc. in January 2016. Opiant Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Santa Monica, California.
About Opiant Pharmaceuticals
Website: https://www.opiant.com
CEO (Chief Executive Officer): Dr. Roger Crystal M.D.
IPO date: 2007-06-04
Contact
Country: US
Address: 233 Wilshirre Boulevard
City: Santa Monica
State: CA
Phone: 310 598 5410
Zip Code: 90401
Other
CIK: 0001385508
ISIN: US6837501039
CUSIP: 683750103
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
